The treatment method of Jaypirca by Eli Lilly for the treatment of lymphocytic leukemia has been approved by the FDA

December 2nd, Eli Lilly announced that their therapy Jaypirca (Pirtobrutinib/Pirtotinib) for the treatment of lymphocytic leukemia has been approved by the U.S. Food and Drug Administration (FDA).

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top